Cite
HARVARD Citation
Wohl, D. et al. (n.d.). The ASSURE study: HIV‐1 suppression is maintained with bone and renal biomarker improvement 48 weeks after ritonavir discontinuation and randomized switch to abacavir/lamivudine + atazanavir1. HIV medicine. 17 (2), pp. 106-117. [Online].